Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Choy

Showing results (301-310 of 316) with videos related to

Pageof 32
Sort By:
RMD Open|June 3, 2016
Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain SetVivian P Bykerk, Clifton O Bingham, Ernest H Choy, et al.
The Journal of Rheumatology|March 4, 2014
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare WorkshopVivian P Bykerk, Elisabeth Lie, Susan J Bartlett, et al.
The Journal of Rheumatology|August 17, 2017
Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop ReportSusan J Bartlett, Skye P Barbic, Vivian P Bykerk, et al.
Annals of the Rheumatic Diseases|July 31, 2007
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesJ N Hoes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|July 24, 2007
EULAR evidence-based recommendations for the management of fibromyalgia syndromeS F Carville, L Arendt-Nielsen, S Arendt-Nielsen, et al.
Annals of the Rheumatic Diseases|September 19, 2009
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesM C van der Goes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|April 25, 2020
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitorsMarie Kostine, Axel Finckh, Clifton O Bingham, et al.
Cell Chemical Biology|February 11, 2026
Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesisPeter Geon Kim, Christopher B Hergott, Aidan P Miller, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 18, 2026
Stabilizing Efficient Perovskite/Silicon Tandem Solar Cells With Amorphous and Asymmetric Hole-Selective ContactsYifan Chen, Chunyu Xu, Zhou Liu, et al.
Clinical and Experimental Rheumatology|June 23, 2021
Diagnostic and therapeutic care pathway for fibromyalgiaPiercarlo Sarzi-Puttini, Valeria Giorgi, Fabiola Atzeni, et al.
Pageof 32

Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
RMD Open|June 3, 2016
Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain SetVivian P Bykerk, Clifton O Bingham, Ernest H Choy, et al.
The Journal of Rheumatology|March 4, 2014
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare WorkshopVivian P Bykerk, Elisabeth Lie, Susan J Bartlett, et al.
The Journal of Rheumatology|August 17, 2017
Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop ReportSusan J Bartlett, Skye P Barbic, Vivian P Bykerk, et al.
Annals of the Rheumatic Diseases|July 31, 2007
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesJ N Hoes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|July 24, 2007
EULAR evidence-based recommendations for the management of fibromyalgia syndromeS F Carville, L Arendt-Nielsen, S Arendt-Nielsen, et al.
Annals of the Rheumatic Diseases|September 19, 2009
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesM C van der Goes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|April 25, 2020
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitorsMarie Kostine, Axel Finckh, Clifton O Bingham, et al.
Cell Chemical Biology|February 11, 2026
Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesisPeter Geon Kim, Christopher B Hergott, Aidan P Miller, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 18, 2026
Stabilizing Efficient Perovskite/Silicon Tandem Solar Cells With Amorphous and Asymmetric Hole-Selective ContactsYifan Chen, Chunyu Xu, Zhou Liu, et al.
Clinical and Experimental Rheumatology|June 23, 2021
Diagnostic and therapeutic care pathway for fibromyalgiaPiercarlo Sarzi-Puttini, Valeria Giorgi, Fabiola Atzeni, et al.
Pageof 32